EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Predicting Human Aluminium Exposure from Vaccinations Using a Physiologically-Based Toxicokinetic Model

Karin Weisser, Niklas Hartung iD, Gaby Wangorsch, Wilhelm Huisinga iD, Brigitte Keller-Stanislawski

Vaccines · 14.04.2026 · 14 (4) · 346

DOI: 10.3390/vaccines14040346 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vaccines, online erschienen am 14.04.2026. Verfasst von Karin Weisser und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division Safety of Biomedicines and Diagnostics, Paul-Ehrlich-Institut (Federal Institute for Vaccines and Biomedicines), Paul-Ehrlich-Straße 7, 6322…. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Poorly soluble aluminium (Al) compounds have successfully been used for decades as adjuvants in vaccines, enabling an effective immune response. Yet the safety of Al exposure from vaccines is consistently questioned, especially regarding infants. Since toxicokinetic data of aluminium after vaccination in humans are not available, model-informed predictions are needed for risk assessment.

Methods

Using a physiologically-based toxicokinetic model, we predicted the Al exposure from i.m. injections of Al-adjuvanted vaccines for full-term neonates to 50-year-old adults following the recommended vaccination schedule in Germany 2025 in addition to the continuous oral background Al exposure from dietary intake.

Results

During the first two years of life, moderate (max. 2-to-3-fold) but transient increases of Al concentrations in plasma and in the relevant target organs liver and bone due to vaccinations were predicted. Increase in brain Al content was 4%. Most importantly, in all tissues, maximum Al levels did not exceed normal levels observed in infants soon after birth or known from adults. In children and adults, the rise in Al concentrations in plasma and tissues due to single vaccinations was marginal. The calculated contribution of vaccinations to the Al body burden at age 50 was negligible.

Conclusions

From a toxicokinetic perspective, the additional Al exposure in full-term infants, children and adults from vaccinations with Al-adjuvanted vaccines according to the current recommended schedules is considered safe. The model has proven a valuable tool for predictions of Al exposure from vaccinations.

Schlagwörter

Stichwörter der Autor:innen

adjuvantsaluminiumcomputer simulationtoxicokineticsvaccination

Autor:innen und Institutionen

  • Division Safety of Biomedicines and Diagnostics, Paul-Ehrlich-Institut (Federal Institute for Vaccines and Biomedicines), Paul-Ehrlich-Straße 7, 63225 Langen, Germany.
  • Institute of Mathematics, University of Potsdam, 14476 Potsdam, Germany.
  • Paul-Ehrlich-Institut (Federal Institute for Vaccines and Biomedicines), Paul-Ehrlich-Straße 7, 63225 Langen, Germany.

ORCID-Profile: Niklas Hartung, Wilhelm Huisinga

Zitieren

APA

Weisser, K., Hartung, N., Wangorsch, G., Huisinga, W., & Keller-Stanislawski, B. (2026). Predicting Human Aluminium Exposure from Vaccinations Using a Physiologically-Based Toxicokinetic Model. Vaccines, 14(4), 346. https://doi.org/10.3390/vaccines14040346

Vancouver

Weisser K, Hartung N, Wangorsch G, Huisinga W, Keller-Stanislawski B. Predicting Human Aluminium Exposure from Vaccinations Using a Physiologically-Based Toxicokinetic Model. Vaccines. 2026;14(4):346. doi:10.3390/vaccines14040346

BibTeX
@article{Weisser2026,
  author = {Weisser, Karin and Hartung, Niklas and Wangorsch, Gaby and Huisinga, Wilhelm and Keller-Stanislawski, Brigitte},
  title = {Predicting Human Aluminium Exposure from Vaccinations Using a Physiologically-Based Toxicokinetic Model},
  journal = {Vaccines},
  year = {2026},
  volume = {14},
  number = {4},
  pages = {346},
  doi = {10.3390/vaccines14040346}
}
Kostenlos starten →